藥品名稱
drug name | Influenza Virus Vaccine 0.5 ml/syringe (AdimFlu-S (QIS)) 安定伏裂解型四價流感疫苗(3歲以上)【公費】 |
| 藥檔狀態 | 停用 |
成 份
Ingredient | Influenza Virus Vaccine |
| 單位含量 | Injectable, Intramuscular : 0.5mL/syringe |
| Dosage Forms | 0.5 mL/syringe |
| 顏 色 | |
| Color | |
| 形 狀 | 針劑/注射 |
| Shape | |
| 劑 型 | |
| Dose Form | |
大 小
Size | |
標 示
outward | |
廠商名稱
Manufacturer | 國光生物科技股份有限公司 |
製 造 商
Manufacturer | 國光生物科技股份有限公司 |
字 號
Product ID | 衛部菌疫製字第000138號 |
藥理分類
Pharmacologic Category | Biologic and Immunologic Agents / Immunizations / Vaccines-Virus (Inactivated) |
作用機轉
Mechanism of action | Promotes immunity to seasonal influenza virus by inducing specific antibody production. Each year the formulation is standardized according to the US Public Health Service. Preparations from previous seasons must not be used. |
| 用途/適應症 | 公費四價流感疫苗 |
| Use |
流感疫苗
|
衛福部核准適用症狀
MOHW approved indications |
預防流感。
【說明：本疫苗適用於3歲以上兒童及成人之主動免疫接種，藉以預防此疫苗所涵蓋之兩種A型及兩種B型流感病毒所引起之流感相關疾病。】
|
| 常用劑量 | 立刻使用0.5cc
(藥品劑量會因人或病情增減，請依照醫師指示服用。) |
| Dose |
3歲以上兒童及成人：一劑0.5mL。
|
懷孕分級
Pregnancy Risk Factor |
B/C
研究報告顯示並無任何胎兒產生不良影響。由於孕婦是流感併發症的高危險族群且可在接種疫苗後提供胎兒保護力，除孕婦已知（或曾有）對本劑成分或雞蛋、雞肉、亦或其他雞來源物有過敏者外，建議孕婦應依流感流行的適用性優先施打本疫苗。
|
| 禁忌症 |
曾對本疫苗中任何成分發生嚴重過敏反應(例如：全身性過敏反應)，或過去曾在注射任何流感疫苗後發生嚴重過敏反應。
|
| Contraindications |
Severe allergic reaction (eg, anaphylaxis) to a previous influenza vaccination or to any component of the formulation
|
| 常見副作用 | 頭痛、發汗、肌肉疼痛、發熱。 |
| Common adverse drug reactions | Headache, Sweating, Muscle pain, Fever. |
| Adverse Reactions |
Cardiovascular: Chest tightness, hypertension
Central nervous system: Chills, drowsiness, fatigue, headache, irritability, malaise, migraine, shivering
Dermatologic: Diaphoresis, ecchymoses
Gastrointestinal: Abdominal pain, anorexia, diarrhea, gastroenteritis, nausea, sore throat, vomiting
Infection: Infection, varicella
Local: Injection site reactions (including bruising, erythema, hematoma at injection site, induration, inflammation, itching at injection site, pain, rash, soreness, swelling at injection site, tenderness at injection site)
Neuromuscular & skeletal: Arthralgia, back pain, myalgia (may start within 6 to 12 hours and last 1 to 2 days; incidence generally equal to placebo in adults; occurs more frequently than placebo in children)
Respiratory: Bronchitis, cough, dyspnea, nasal congestion, nasopharyngitis, oropharyngeal pain, pharyngitis, pharyngolaryngeal pain, rhinitis, rhinorrhea, upper respiratory tract infection, wheezing
Miscellaneous: Fever
|
監測
Monitoring |
Monitor for anaphylaxis and syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.
|
| 警語與注意事項 | 冷藏保存。 |
| Warnings & precautions | Should be refrigerated between 2-8℃ . |
| 針劑溶解條件 |
|
| 針劑稀釋條件 |
|
| 針劑不相容性 |
目前尚無相關臨床試驗數據或研究報告，因此不建議將本劑與其他廠牌季節性流感疫苗混用。
|
| 針劑施打條件 |
肌肉注射。不可直接注射血管內。
冷藏庫取出時，待回復到室溫後，搖勻後才使用。
|
| 針劑保存安定性 |
避光儲存在2~8℃，避免凍結。
|
最近修改日期時間
Updated | 1/14/2019 11:23:56 AM |
|
現用藥品
Available
|
停用藥品
Old item
|
藥品仿單
Package insert sheet
|
|
二維條碼
QR code
|
|